Navigation Links
Curemark Announces Senior Executive Promotions
Date:10/7/2009

RYE, N.Y., Oct. 7 /PRNewswire/ -- Curemark, LLC, a drug research and development company focused on the treatment of neurological diseases, announced the promotions of two senior executives. Dr. Elisa Zinberg has been appointed senior vice president of operations, and Matthew Heil, Ph.D., senior vice president of drug development. Both were vice presidents of the company.

Zinberg oversees day-to-day management of Curemark and is responsible for the implementation of the company's strategic plan and clinical program. Prior to joining Curemark in 2008, she was chief operating officer of The Masters Circle, LLC, a practice management and leadership development company, where she directed 11 departments and grew the company more than 25 percent. Previously, she was in private practice for more than a decade, running a high-volume, family-based natural health care practice with multiple support staff.

Heil, who has been with Curemark since its founding in 2004, oversees all aspects of drug development and manufacturing. Previously, he served as vice president for development operations at Auriga Laboratories, Inc. in Atlanta. He spent the prior 15 years as a pharmaceutical development consultant with the Delphi Group, Ltd. and BioInnovators, Ltd. in White Plains, New York. Heil was a member of the faculty of medicine at New York Medical College and co-director of the immunotype clinical laboratory at Westchester County Medical Center.

Curemark is developing a treatment for autism based on research by company founder and CEO Dr. Joan Fallon that showed enzyme deficiencies in autistic children, resulting in an inability to digest protein. The inability to digest protein affects the production of amino acids, the building blocks of chemicals essential for brain function. The company has Investigational New Drug (IND) authorization from the FDA and is now conducting Phase III clinical trials for its CM-AT autism treatmen
'/>"/>

SOURCE Curemark, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Curemark CEO Presents at Epigenomics Conference
2. Curemark Closes Series A Financing
3. Curemark Appoints Preeminent Pediatrics Gastroenterologist
4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
5. MedShape Solutions, Inc. Appoints Jack Blair and Tom Hills to Board of Directors; Announces Additions to Management Team
6. Odyssey Thera Announces Achievement of Pfizer Drug Candidate Milestones
7. NuVasive Announces Conference Call and Webcast of Third Quarter 2009 Results
8. Catalyst Pharmaceutical Partners, Inc. Announces the Closing of $3.97 Million Registered Direct Offering
9. BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
10. BD Announces FDA 510(k) Clearance of BD Vacutainer(R) Rapid Serum Blood Collection Tube
11. Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Biopharmaceutical Industry Leads Manufacturing Sector in ... on top as the country,s manufacturing leader in innovation ... ndp│analytics. According to the  analysis , the industry had ... last decade, accounting for 27 percent of average annual ... Short Video on Medicare Part D - Medicare ...
(Date:3/27/2015)... 27, 2015 The Temple Health & Bioscience District ... 5,000-square-foot building at 1802 South First St. in the Temple ... the City of Temple to receive ... the Central Texas Veterans Health Care System, the new facility ... early stage biotechnology and life science companies. ...
(Date:3/27/2015)... A new report from Kalorama Information says that ... Chile , Colombia ... IVD firms.  The healthcare research firm said that while ... the Latin American continent with a population of over 200 ... However, the country,s regional economic clout does not necessarily ensure ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... 24, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... Repella as Senior Vice President, Chief Commercial Officer of ... 25 years of experience in the biotech/pharmaceutical industry, including ... development and commercial operations.   "We are ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... 15mg, and 20mg strengths of olanzapine orally disintegrating tablets, ... According to IMS Health data, annual sales in the ... Important information about olanzapine ODT ...
Cached Medicine Technology:Vanda Pharmaceuticals Appoints Chief Commercial Officer 2Par Pharmaceutical Begins Shipment of Generic Zyprexa® Zydis® 2
(Date:3/28/2015)... 28, 2015 Could genetic code determine ... study by researchers at the Harvard T.H. ... the support of the Coffee and Caffeine Genetics Consortium ... this past fall, the study—one of several recent HSPH ... data from more than 120,000 regular coffee drinkers of ...
(Date:3/28/2015)... a bite of warm, gooey pepperoni pizza, and your ... stomach, ready to break down your meal. In many ... amok, triggering a burning sensation in the chest. Heartburn ... Americans have heartburn at least once a month. The ... can be stopped. , Heartburn or acid reflux symptoms ...
(Date:3/28/2015)... York, New York (PRWEB) March 28, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) involving devices manufactured by C.R. Bard, ... litigation underway in U.S. District Court, Southern District ... S. Grand, is serving on the Plaintiffs’ Steering ... 24th, the Court has granted certain defendants named ...
(Date:3/28/2015)... Emergency Medical Care (EMC), a New ... recently commemorated its three-year anniversary of being the only ... to 24-hour urgent care, Emergency Medical Care offers its ... time, Emergency Medical Care’s Urgent Care NYC ... eye injuries, ear infections, fevers, insect bites, burns, animal ...
(Date:3/28/2015)... March 28, 2015 An article in ... which could prove critical to organizations that deal with ... critical aspect of data security, is worsening . ... security report, every major category out of the twelve ... testing. “With all the craziness that has gone on ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4
... associated with VIB and KU Leuven, succeeded in undoing ... leads to Parkinson,s using vitamin K2. His discovery gives ... collaboration with colleagues from Northern Illinois University (US) and ... the authorative journal Science ., "It appears from ...
... HealthDay Reporter , THURSDAY, May 10 (HealthDay News) ... cells to enhance their healing potential may help people with ... suggests. Researchers developed the treatment by culturing a ... increase the amount of immune cells and stem cells that ...
... , THURSDAY, May 10 (HealthDay News) -- Inducing labor after ... can reduce an infant,s risk of death before, during or ... a new study says. However, babies born after induced ... hospital,s infant intensive care unit, said researchers led by Sarah ...
... THURSDAY, May 10 (HealthDay News) -- A new weight-loss ... and Drug Administration showed promising results in a recent ... a combination of the drugs phentermine and topiramate, experienced ... health problems, the study found. The findings were reported ...
... is a major first line defense against breast cancer. ... A study published in BioMed Central,s open access journal ... signatures, for TOP2A and β-tubulin can be used to ... of personalized medicine in cancer treatment is to target ...
... A review of 30 years of life-threatening asthma cases in ... admissions for the condition have dropped 74 percent. The study, ... University Hospital between 1980 and 2010, also showed intubation in ... in longer hospital stays. UT Medicine is the clinical ...
Cached Medicine News:Health News:Vitamin K2: New hope for Parkinson's patients? 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 2Health News:Stem Cell Study Shows Promising Results Against Heart Failure 3Health News:Induced Labor Late in Pregnancy Has Pros, Cons 2Health News:New Weight-Loss Drug Shows Promise in Trial 2Health News:New Weight-Loss Drug Shows Promise in Trial 3Health News:ICU stays for worst asthma drop 74 percent, review finds 2
... supplied on Smart Cards. Insert the card and ... and turns itself off after the programmed time. ... duration of treatments. Simply provide your patient with ... their progress on the next visit.,The initial set ...
... timely, high-quality and accurate,ECG results ... The,Quinton Eclipse Premier allows you ... results,and make a diagnosis quicker ... capabilities.,Workload is further streamlined with ...
A sterile, cost-effective solution to eliminating the risk of cross-contamination....
... profile) is specifically designed for use on ... The MicroTouch LP attaches to tables on ... the user complete freedom to move the ... loss of position of the instrument or ...
Medicine Products: